Drug side effects have led to increased ER visits in older Americans
(By Ed Silverman for STAT) Side effects from medication are causing more older Americans to visit emergency rooms and leading
Read More
Part D/Prescription Drugs
Mylan refuses to testify at Senate hearing about EpiPen rebates to Medicaid
(By Ed Silverman for STAT) In a move that angered a key Senate lawmaker, Mylan Pharmaceuticals has declined to testify
Read MoreOmniPod: Why is it Still Not Covered under Medicare?
In an opinion editorial for the Morning Consult, George Grunberger, M.D., chairman of the Grunberger Diabetes Institute, urges the Centers
Read MoreDo You Know How Medicare is Funded?
In Philip Moeller’s column for PBS Newshour which is an excerpt from this new book, explains the basics on how
Read MoreMost doctors don’t cite cost as a factor when deciding treatments
(By Ed Silverman for STAT) The rising cost of medicines may be a growing problem for many Americans, but a
Read MoreBiomedical Researchers Ponder Future After Trump Election
(By Richard Harris for NPR) What could the world of medical research look like under a Trump administration? Continue reading
Read MoreUpdated Medicare and Medicaid Drug Spending Dashboard
(Source -blog.cms.gov) Announcement November 14, 2016 The increased costs of prescription drugs are one of the most critical items for
Read MoreState Medicaid programs continue to restrict access to hepatitis C drugs
(By Ed Silverman for STAT) Over the past two years, state Medicaid programs have done a better job of disclosing
Read MoreSeven Simple Steps
With the quickly approaching deadline for enrolling in Medicare Part D program; have you picked the right prescription drug plan for
Read More‘Pink,’ a synthetic opioid linked to nearly 50 US deaths, to be banned
(By Eric Boodman for STAT) The Drug Enforcement Administration is poised to ban a little-known drug called U-47700, also known
Read More